Levetiracetam Sandoz 100 Mg/Ml

Levetiracetam, the active ingredient in Levetiracetam Sandoz 100 Mg/Ml, is an anticonvulsant presented as a 100 mg/mL intravenous solution for intravenous use. It is used as adjunctive therapy for partial‑onset seizures and generalized tonic‑clonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Sandoz 100 Mg/Ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide.

Levetiracetam is an antiepileptic agent indicated for seizure disorders.

Partial‑onset seizures: reduces seizure frequency when added to existing therapy. Generalized tonic‑clonic seizures: provides adjunctive control in refractory generalized seizures. Epilepsy adjunctive therapy: improves overall seizure management as part of a comprehensive treatment plan.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis - Stevens‑Johnson syndrome or other severe skin eruptions - Blood dyscrasias such as neutropenia or thrombocytopenia - Mood alterations, including depression or suicidal ideation - Significant behavioral changes requiring medical attention

When using Levetiracetam Sandoz 100 Mg/Ml, consider the following safety measures.

Renal impairment: dose adjustment may be required based on renal function. Hepatic impairment: monitor liver enzymes and adjust therapy if needed. Concomitant CNS depressants: may increase sedation and should be used with caution. Pregnancy: safety data are limited; weigh potential benefits against risks. Behavioral monitoring: observe patients for mood changes or aggression. Store at ambient temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with several medications; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: may decrease levetiracetam efficacy. - Phenytoin: may lower levetiracetam levels, reducing seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Sedative hypnotics (e.g., benzodiazepines): increased sedation risk. - Antidepressants: monitor for enhanced mood changes or suicidal thoughts.